Kirsten Eibl‐Lindner

480 total citations
23 papers, 391 citations indexed

About

Kirsten Eibl‐Lindner is a scholar working on Ophthalmology, Radiology, Nuclear Medicine and Imaging and Molecular Biology. According to data from OpenAlex, Kirsten Eibl‐Lindner has authored 23 papers receiving a total of 391 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Ophthalmology, 9 papers in Radiology, Nuclear Medicine and Imaging and 8 papers in Molecular Biology. Recurrent topics in Kirsten Eibl‐Lindner's work include Intraocular Surgery and Lenses (13 papers), Ocular Infections and Treatments (7 papers) and Retinal and Macular Surgery (7 papers). Kirsten Eibl‐Lindner is often cited by papers focused on Intraocular Surgery and Lenses (13 papers), Ocular Infections and Treatments (7 papers) and Retinal and Macular Surgery (7 papers). Kirsten Eibl‐Lindner collaborates with scholars based in Germany, United States and France. Kirsten Eibl‐Lindner's co-authors include Christian Wertheimer, Armin Wolf, Anselm Kampik, Raffael Liegl, Wolfgang J. Mayer, Claudia Priglinger, Jakob Siedlecki, Marcus Kernt, Siegfried Priglinger and Denitsa Docheva and has published in prestigious journals such as Investigative Ophthalmology & Visual Science, European Journal of Pharmaceutics and Biopharmaceutics and Journal of Cataract & Refractive Surgery.

In The Last Decade

Kirsten Eibl‐Lindner

23 papers receiving 376 citations

Peers

Countries citing papers authored by Kirsten Eibl‐Lindner

Since Specialization

Citations

This map shows the geographic impact of Kirsten Eibl‐Lindner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kirsten Eibl‐Lindner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kirsten Eibl‐Lindner more than expected).

Fields of papers citing papers by Kirsten Eibl‐Lindner

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kirsten Eibl‐Lindner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kirsten Eibl‐Lindner. The network helps show where Kirsten Eibl‐Lindner may publish in the future.

Co-authorship network of co-authors of Kirsten Eibl‐Lindner

This figure shows the co-authorship network connecting the top 25 collaborators of Kirsten Eibl‐Lindner. A scholar is included among the top collaborators of Kirsten Eibl‐Lindner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kirsten Eibl‐Lindner. Kirsten Eibl‐Lindner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Title	Journal	Authors	Indexed citations
1	Pharmacological drug screening to inhibit uveal melanoma metastatic cells either via EGF-R, MAPK, mTOR or PI3K	International Journal of Ophthalmology	Stefan Kassumeh, Nikolaus Luft et al.	4
2	Supercritical fluid technology for the development of innovative ophthalmic medical devices: Drug loaded intraocular lenses to mitigate posterior capsule opacification	European Journal of Pharmaceutics and Biopharmaceutics	Yasmine Masmoudi, Christian Wertheimer et al.	33
3	Combined VEGF/PDGF inhibition using axitinib induces αSMA expression and a pro-fibrotic phenotype in human pericytes	Graefe s Archive for Clinical and Experimental Ophthalmology	Jakob Siedlecki, Christian Wertheimer et al.	14
4	The intraocular lens as a drug delivery device for an epidermal growth factor–Receptor inhibitor for prophylaxis of posterior capsule opacification	Acta Ophthalmologica	Christian Wertheimer, Jakob Siedlecki et al.	20
5	Combined VEGF and PDGF inhibition for neovascular AMD: anti-angiogenic properties of axitinib on human endothelial cells and pericytes in vitro	Graefe s Archive for Clinical and Experimental Ophthalmology	Jakob Siedlecki, Christian Wertheimer et al.	40
6	A cell culture technique for human epiretinal membranes to describe cell behavior and membrane contraction in vitro	Graefe s Archive for Clinical and Experimental Ophthalmology	Christian Wertheimer, Kirsten Eibl‐Lindner et al.	8
7	BILATERAL VISUAL FIELD DEFECTS IN A PATIENT TREATED WITH THE MEK AND BRAF INHIBITORS TRAMETINIB AND DABRAFENIB FOR MELANOMA OF UNKNOWN ORIGIN	Retinal Cases & Brief Reports	Jakob Siedlecki, Marc J. Mackert et al.	7
8	Incidence of secondary glaucoma after treatment of uveal melanoma with robotic radiosurgery versus brachytherapy	Acta Ophthalmologica	Jakob Siedlecki, Simon F. Leicht et al.	18
9	The Intraocular Lens as a Drug Delivery Device: In Vitro Screening of Pharmacologic Substances for the Prophylaxis of Posterior Capsule Opacification	Investigative Ophthalmology & Visual Science	Christian Wertheimer, Stefan Kassumeh et al.	30
10	Robotic radiosurgery for the treatment of medium and large uveal melanoma	Melanoma Research	Kirsten Eibl‐Lindner, Christoph Fürweger et al.	44
11	Erufosine, a phosphoinositide-3-kinase inhibitor, to mitigate posterior capsule opacification in the human capsular bag model	Journal of Cataract & Refractive Surgery	Christian Wertheimer, Daniel Kook et al.	12
12	EGFR inhibitor Gefitinib attenuates posterior capsule opacification in vitro and in the ex vivo human capsular bag model	Graefe s Archive for Clinical and Experimental Ophthalmology	Christian Wertheimer, Jakob Siedlecki et al.	26
13	EGFR-Blockade With Erlotinib Reduces EGF and TGF-β2 Expression and the Actin-Cytoskeleton Which Influences Different Aspects of Cellular Migration in Lens Epithelial cells	Current Eye Research	Christian Wertheimer, Raffael Liegl et al.	22
14	Vemurafenib as a therapeutic option for treatment of melanoma	Investigative Ophthalmology & Visual Science	Simon F. Leicht, Christian Wertheimer et al.	1
15	Intraokularlinse als Medikamententräger	Der Ophthalmologe	Kirsten Eibl‐Lindner, Raffael Liegl et al.	6
16	Attenuation of human lens epithelial cell spreading, migration and contraction via downregulation of the PI3K/Akt pathway	Graefe s Archive for Clinical and Experimental Ophthalmology	Raffael Liegl, Christian Wertheimer et al.	15
17	EGF receptor inhibitor erlotinib as a potential pharmacological prophylaxis for posterior capsule opacification	Graefe s Archive for Clinical and Experimental Ophthalmology	Christian Wertheimer, Raffael Liegl et al.	22
18	Inhibition of TLR3-Mediated Proinflammatory Effects by Alkylphosphocholines in Human Retinal Pigment Epithelial Cells	Investigative Ophthalmology & Visual Science	Markus Wörnle, Monika Merkle et al.	20
19	Alkylphosphocholine hemmen die Proliferation und Anhaftung von Linsenepithelzellen	Der Ophthalmologe	Raffael Liegl, Marcus Kernt et al.	2
20	The safety profile of alkylphosphocholines in the model of the isolated perfused vertebrate retina	Graefe s Archive for Clinical and Experimental Ophthalmology	Matthias Lüke, Kai Januschowski et al.	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact